Table 1.
Patient Characteristics
| N (%)* | ||
|---|---|---|
|
| ||
| # Patients | 37 | |
| Age at Treatment, years | Median (Range) | 67 (42–82) |
| Gender | Male | 32 (86.5) |
| Female | 5 (13.5) | |
| Race | White | 29 (78.4) |
| Asian | 4 (10.8) | |
| Black | 3 (8.1) | |
| Other | 1 (2.7) | |
| BMI | Median (Range) (N=35) | 26.9 (17.9–37.0) |
| Extrahepatic Disease | Yes | 14 (37.8) |
| Extrahepatic Site | Lymph Nodes | 8 (21.6) |
| Lungs | 6 (16.2) | |
| None | 23 (62.2) | |
| Portal Vein Thrombus | Yes | 4 (10.8) |
| UCSF Criteria for Transplant | Yes | 8 (21.6) |
| Milan Criteria for Transplant | Yes | 3 (8.1) |
| Pre-Treatment Meld Score | Median (Range) (N=37) | 10 (6–20) |
| BCLC Stage | A | 11 (29.7) |
| B | 12 (32.4) | |
| C | 14 (37.8) | |
| AFP | Median (Range) (N=36) | 12.9 (2.3–51123) |
| History/Comorbidities | ||
| Charlson Comorbidity Index | Median (Range) | 6 (4–13) |
| Prior Cancer | Yes | 8 (21.6) |
| Family History of Cancer | Yes | 16 (43.2) |
| History of Smoking | Yes | 25 (67.6) |
| History of Alcohol Use | Yes | 14 (37.8) |
| Hepatitis B | Yes | 9 (24.3) |
| Hepatitis C | Yes | 13 (35.1) |
| Hepatitis B or C | Yes | 21 (56.8) |
| Prior Liver Ablation | Yes | 4 (10.8) |
| Prior Liver Surgery | Yes | 4 (10.8) |
*
Numbers represent frequency with percent of total in parentheses unless otherwise stated.
UCSF=University of California, San Francisco; BCLC=Barcelona Clinic Liver Cancer